Michelle Baker-Jones

Michelle Baker-Jones is a member of the Psychedelic Research Team at Imperial College London. She was a lead guide on Psilodep 2 trial, which is comparing psilocybin to antidepressants as a form of treatment for depression.

She also offers individual psychedelic integration for people who are struggling to process psychedelic experiences and co-facilitates a monthly Psychedelic Integration group with Rosalind Watts.

Michelle is also an integrative psychotherapeutic counsellor in private practice, based in London.